Status:

COMPLETED

Implementation and Effectiveness of Engagement and Collaborative Management to Proactively Advance Sepsis Survivorship

Lead Sponsor:

Wake Forest University Health Sciences

Collaborating Sponsors:

National Institute of Nursing Research (NINR)

Conditions:

Sepsis

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The purpose of this study is to evaluate if implementation of the Sepsis Transition and Recovery (STAR) program within a large healthcare system will improve outcomes for high-risk patients with suspe...

Detailed Description

BACKGROUND Sepsis is a common and life-threatening condition defined by organ dysfunction due to a dysregulated response to infection (Fleischmann, 2016). Aggressive early sepsis identification and t...

Eligibility Criteria

Inclusion

  • At least 18 years of age upon admission
  • Suspected infection
  • Oral/parenteral antibiotic or bacterial culture order within 24 hours of emergency department presentation; and
  • Evidence of systemic inflammatory response (i.e., at least two abnormal of temperature; heart rate; respiratory rate; and WBC count or bands)
  • Evidence of organ dysfunction (i.e., at least two points on either Quick Sepsis-related Organ Failure Assessment or Sepsis-related Organ Failure Assessment risk tools)
  • Deemed as high risk for 90-day readmission using risk-scoring models
  • Not discharged at the time of patient list generation

Exclusion

  • Patients with a change in code status (i.e., do not resuscitate, do not intubate) within 24 hours after infection onset due to presumed limitation of aggressive treatment
  • Patients who reside \> 2.5 hours drive time from the treating hospital
  • Patients actively enrolled in a different care management program at time of admission
  • Patient has been randomized previously.

Key Trial Info

Start Date :

July 1 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2024

Estimated Enrollment :

3894 Patients enrolled

Trial Details

Trial ID

NCT04495946

Start Date

July 1 2020

End Date

April 1 2024

Last Update

September 19 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Atrium Health

Charlotte, North Carolina, United States, 28203